These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 15867617
21. Treatment of genital herpes infections in HIV-infected patients. Foley E, Patel R. J HIV Ther; 2004 Feb; 9(1):14-8. PubMed ID: 15071425 [Abstract] [Full Text] [Related]
22. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy. Yi TJ, Walmsley S, Szadkowski L, Raboud J, Rajwans N, Shannon B, Kumar S, Kain KC, Kaul R, Tan DH. Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220 [Abstract] [Full Text] [Related]
23. Health care seeking among men with genital ulcer disease in South Africa: correlates and relationship to human immunodeficiency virus-1 and herpes simplex virus type 2 detection and shedding. Leichliter JS, Lewis DA, Sternberg M, Habel MA, Paz-Bailey G. Sex Transm Dis; 2011 Sep; 38(9):865-70. PubMed ID: 21844743 [Abstract] [Full Text] [Related]
24. Detection of a new variant of herpes simplex virus type 2 among HIV-1-infected individuals. Burrel S, Abrao EP, Désiré N, Seang S, Caumes E, Agut H, Boutolleau D. J Clin Virol; 2013 Jul; 57(3):267-9. PubMed ID: 23567026 [No Abstract] [Full Text] [Related]
25. Outbreaks of genital herpes: effects on plasma HIV type 1 viral loads in individuals receiving highly active antiretroviral therapy. Lee V, Foley E, Barton SE, Patel R. J Infect Dis; 2004 Dec 01; 190(11):2057-8. PubMed ID: 15529276 [No Abstract] [Full Text] [Related]
27. HIV-1 and herpes simplex virus type-2 genital shedding among co-infected women using self-collected swabs in Chiang Rai, Thailand. Forhan SE, Dunne EF, Sternberg MR, Whitehead SJ, Leelawiwat W, Thepamnuay S, Chen C, Evans-Strickfaden T, McNicholl JM, Markowitz LE. Int J STD AIDS; 2012 Aug 30; 23(8):560-4. PubMed ID: 22930292 [Abstract] [Full Text] [Related]
28. Research gaps in defining the biological link between HIV risk and hormonal contraception. Murphy K, Irvin SC, Herold BC. Am J Reprod Immunol; 2014 Aug 30; 72(2):228-35. PubMed ID: 24548147 [Abstract] [Full Text] [Related]
29. Intravenous cidofovir for pseudotumoral genital herpes simplex virus infection in two persons living with human immunodeficiency virus (HIV). Jumpertz M, Blaizot R, Couppié P, Bertin C. Int J Dermatol; 2023 Apr 30; 62(4):e212-e213. PubMed ID: 36691799 [No Abstract] [Full Text] [Related]
30. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences. Levine JP. J Fam Pract; 2004 Nov 30; 53(11):904-13. PubMed ID: 15527729 [No Abstract] [Full Text] [Related]
31. Effect of aciclovir on HIV-1 acquisition in HSV-2-positive patients. Hudson CP. Lancet; 2008 Oct 11; 372(9646):1298; author reply 1298-9. PubMed ID: 18929897 [No Abstract] [Full Text] [Related]
32. Beyond politics: new medical concerns for contraceptive users. Wallis L. Am J Nurs; 2012 Jul 11; 112(7):19. PubMed ID: 22739598 [Abstract] [Full Text] [Related]
33. Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women. Mbopi-Kéou FX, Legoff J, Grésenguet G, Si-Mohamed A, Matta M, Mayaud P, Andreoletti L, Malkin JE, Weiss H, Brown D, Bélec L. J Acquir Immune Defic Syndr; 2003 Jun 01; 33(2):121-4. PubMed ID: 12794542 [No Abstract] [Full Text] [Related]
34. Thrombocytopenic purpura with depot medroxyprogesterone acetate and subsequent use of contraceptive implant: making decisions in the absence of evidence. Holman R, Stephen G. J Fam Plann Reprod Health Care; 2005 Oct 01; 31(4):333-4. PubMed ID: 16274569 [No Abstract] [Full Text] [Related]
35. The pathogenesis underlying the interaction of HIV and herpes simplex virus after co-infection. Cunningham AL, Dwyer DE. J HIV Ther; 2004 Feb 01; 9(1):9-13. PubMed ID: 15071424 [Abstract] [Full Text] [Related]
36. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. Lavreys L, Baeten JM, Martin HL, Overbaugh J, Mandaliya K, Ndinya-Achola J, Kreiss JK. AIDS; 2004 Mar 05; 18(4):695-7. PubMed ID: 15090778 [No Abstract] [Full Text] [Related]
37. Pseudotumoral recto-sigmoid herpes simplex virus type 2 in an HIV-infected patient: Dramatic improvement with thalidomide. Charles P, Richaud C, Beley S, Bodard L, Simon M. J Clin Virol; 2016 May 05; 78():12-3. PubMed ID: 26946154 [No Abstract] [Full Text] [Related]
38. The early work on hormonal contraceptive use and HIV acquisition. Martin HL, Richardson BA, Mandaliya K, Achola JO, Overbaugh J, Kreiss JK. J Acquir Immune Defic Syndr; 2005 Mar 05; 38 Suppl 1():S12-4. PubMed ID: 15867600 [No Abstract] [Full Text] [Related]
39. A prospective study of hormonal contraceptive use and cervical shedding of herpes simplex virus in human immunodeficiency virus type 1-seropositive women. McClelland RS, Wang CC, Richardson BA, Corey L, Ashley RL, Mandaliya K, Ndinya-Achola J, Bwayo JJ, Kreiss JK. J Infect Dis; 2002 Jun 15; 185(12):1822-5. PubMed ID: 12085333 [Abstract] [Full Text] [Related]
40. The use of long-acting contraceptives in adolescents. Harel Z, Cromer B. Pediatr Clin North Am; 1999 Aug 15; 46(4):719-32. PubMed ID: 10494253 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]